Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
ESMO 2021Adjuvant Pembro Success in Early Melanoma Raises QuestionsAdjuvant pembrolizumab significantly improved recurrence-free survival in stage 2B/C melanoma in KEYNOTE 716, but which patients benefit most and what does this mean for treatment down the line?
Oncologist Distress and Burnout Has Increased During COVIDFeelings of distress and burnout among oncology professionals have increased during the COVID-19 pandemic and "urgent measures"
are needed to improve well-being, suggests the largest survey to date.
Medscape Medical News, Sept 14, 2020
'Paradigm Shift' in Gastric Junction Cancers With NivolumabNivolumab immunotherapy could soon be used in the first-line in gastric or gastroesophageal junction cancers, improving the
traditionally poor outcomes seen with chemotherapy, show latest trials.
